Clinical trial
Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to…
NCT00176137 · Heidelberg University, Other · Completed
Key facts
| NCT number | NCT00176137 |
|---|---|
| Title | Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC) |
| Official title | Cisplatin/Etoposide Followed by Twice-Daily Chemoradiation (hfRT/CT) Versus Cisplatin/Etoposide Alone Before Surgery in Stage III Non-Small Cell Lung Cancer. A Phase III Trial of the German Lung Cancer Cooperative Group (GLCCG) |
| Lead sponsor | Heidelberg University, Other |
| Collaborators | University Hospital Muenster Lung Clinic Hemer Kreiskrankenhaus Diekholzen University Hospital, Saarland FLT Berlin / Buch |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Procedure |
| Interventions | preoperative radiochemotherapy |
| Enrollment | 500 |
| Start date | Oct 1, 1995 |
| Completion | Sep 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 22, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: